<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000726'>Dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>) is the second most frequent neuropathologically diagnosed degenerative dementing illness </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical characteristics are <z:hpo ids='HP_0000726'>progressive dementia</z:hpo>, Parkinson syndrome, fluctuations of cognitive functions, vigilance and attention, <z:hpo ids='HP_0002367'>visual hallucinations</z:hpo> (usually detailed and well described), <z:hpo ids='HP_0000716'>depression</z:hpo>, <z:e sem="disease" ids="C0751772" disease_type="Disease or Syndrome" abbrv="">REM-sleep behavior disorder</z:e>, adverse responses to standard doses of <z:chebi fb="25" ids="35476">neuroleptics</z:chebi>, <z:hpo ids='HP_0002527'>falls</z:hpo>, <z:hpo ids='HP_0001279'>syncopes</z:hpo>, systematized <z:hpo ids='HP_0000746'>delusions</z:hpo>, and non-<z:hpo ids='HP_0002367'>visual hallucinations</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Mean age at disease <z:hpo ids='HP_0003674'>onset</z:hpo> ranges between 60 and 68 years </plain></SENT>
<SENT sid="3" pm="."><plain>Male persons are more frequently affected than female </plain></SENT>
<SENT sid="4" pm="."><plain>Disease duration is six to seven years </plain></SENT>
<SENT sid="5" pm="."><plain>The differential diagnoses of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> are <z:hpo ids='HP_0000726'>dementia</z:hpo> of the Alzheimer-type, <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e>, subcortical arteriosclerotic <z:hpo ids='HP_0001298'>encephalopathy</z:hpo>, <z:e sem="disease" ids="C0038868" disease_type="Disease or Syndrome" abbrv="PSNP1">progressive supranuclear palsy</z:e>, multiple system <z:mpath ids='MPATH_127'>atrophy</z:mpath>, and, in rare cases, <z:e sem="disease" ids="C0022336" disease_type="Disease or Syndrome" abbrv="">Creutzfeldt-Jakob disease</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The genetic background of the disease is unclear </plain></SENT>
<SENT sid="7" pm="."><plain>Magnetic resonance imaging and single <z:chebi fb="23" ids="30212">photon</z:chebi> emission tomography can contribute to the diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>The disease is treated with <z:chebi fb="3" ids="15765">L-dopa</z:chebi>, atypical <z:chebi fb="25" ids="35476">neuroleptics</z:chebi>, <z:chebi fb="0" ids="38462">acetylcholine esterase inhibitors</z:chebi>, antihypotensive agents, and peripheral anticholinergic and alpha-receptor-blocking <z:chebi fb="8" ids="52217">medicaments</z:chebi> to improve <z:hpo ids='HP_0000011'>neurogenic bladder</z:hpo> dysfunction </plain></SENT>
</text></document>